IQV Q2 Deep Dive: Broad-Based Growth and AI-Driven Momentum Across Segments

Clinical research organisation IQVIA reported strong Q2 growth, with revenue up 8.7% YoY to $4.37 billion, driven by an acceleration in outsourcing from pharmaceutical clients and the adoption of its AI tools. The company highlighted that AI is enhancing clinical trial design and patient recruitment, leading to higher win rates against competitors.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.